Vincerx Pharma Inc. (VINC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Vincerx Pharma Inc. (VINC:NASDAQ), powered by AI.

Current Price
$0.01
P/E Ratio
-0.0
Market Cap
24,674
Sector
Healthcare
What is the Vincerx Pharma Inc. stock price forecast?

Vincerx Pharma Inc. is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is Vincerx Pharma Inc. insider trading activity?

View the latest insider trading data for Vincerx Pharma Inc. on Alpha Lenz.

What is Vincerx Pharma Inc.'s P/E ratio?

Vincerx Pharma Inc.'s P/E ratio is -0.0.

Vincerx Pharma Inc.

NASDAQ · VINC
$0.01+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Vincerx Pharma Inc.'s future dividend policy...
Alpha Chat Insight

Vincerx Pharma Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -431.3%.

Ask for details

Company Overview

Vincerx Pharma Inc. is a dynamic company operating in the promising sector of biotechnology and pharmaceuticals. Its primary focus is on the development of targeted therapeutics to treat cancer, leveraging innovative strategies to enhance patient outcomes. Vincerx Pharma is committed to addressing significant unmet medical needs by developing a robust pipeline of small molecules and bioconjugates aimed at the treatment of hematologic and solid tumors. A notable feature of Vincerx Pharma's approach involves the use of advanced drug design technologies, which aim to improve specificity and reduce side effects associated with cancer treatment. Positioned within the highly competitive biotech industry, Vincerx Pharma plays a critical role in the advancement of oncology therapies, drawing attention from both the medical community and the financial markets. Through strategic research and development efforts, Vincerx Pharma strives to introduce groundbreaking therapies, contributing to the broader realm of personalized medicine and biotechnology advancements.

CEODr. Raquel E. Izumi Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees12

Company Statistics

FY 2024

Profile

$24.67KMarket Cap
$0.00Revenue
0.00Shares Out
12Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.00P/E
0.01P/B
N/AEV/Sales
0.16EV/EBITDA
-0.00P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-229.38%ROA
-431.29%ROE
-239.97%ROIC

Financial Health

$4.99MCash & Cash Equivalents
$294.00KNet Debt
193.87%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Vincerx Pharma Inc. (ticker: VINC) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 12 employees. Market cap is $24,674.

The current price is $0.013 with a P/E ratio of -0x and P/B of 0.01x.

ROE is -431.29%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Vincerx Pharma Inc. (VINC) Stock Forecast 2026 $0.01 — Price, Financials & Analyst Targets | Alpha Lenz